Envase
Envase
METHOD FOR MANUFACTURING A LABORATORY OBJECT SUITABLE FOR CONDUCTING EXPERIMENTS WITH PHARMACEUTICAL OR COSMETIC ACTIVE INGREDIENTS
26/06/2025 -
The invention relates to a method for manufacturing a laboratory object suitable for conducting experiments with pharmaceutical or cosmetic active ingredients without same being absorbed or...
CONTROLLED-RELEASE FORMULATION COMPRISING CAFFEINE, AND PREPARATION METHOD THEREFOR
26/06/2025 -
The present invention relates to an orally administered formulation comprising caffeine as an active ingredient and having a drug-release controlling property, and a method for preparing same by...
CRYSTALLINE FORMS OF AN IMIDAZOPYRIDINE DERIVATIVE
26/06/2025 -
Polymorphic forms A, B, C, D, E, and F of Compound 1, as shown below, have been discovered and formulated with pharmaceutically acceptable excipients to form tablets and capsules.
METHODS OF PREPARING DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF OCULAR DISEASES
26/06/2025 -
The present disclosure relates to methods of preparing biodegradable ocular implants containing edonentan, or a pharmaceutically acceptable salt thereof. The disclosure also relates to...
METHODS OF PREPARING DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF OCULAR DISEASES
26/06/2025 -
The present disclosure relates to methods of preparing biodegradable ocular implants containing edonentan, or a pharmaceutically acceptable salt thereof. The disclosure also relates to...
MATRIX TABLETS OF DEXPRAMIPEXOLE AND METHODS OF MANUFACTURING AND USE THEREOF
26/06/2025 -
The present disclosure relates to sustained release pharmaceutical compositions of dexpramipexole, or a pharmaceutically acceptable salt thereof. In some aspects, the present disclosure relates to...
COMPUESTO NOVEDOSO Y COMPOSICION FARMACEUTICA QUE COMPRENDE LA MISMA COMO INGREDIENTE ACTIVO
29/04/2025 -
La presente invencion se refiere a un compuesto representado por la formula quimica 1, un estereoisomero del mismo o una sal farmaceuticamente aceptable del mismo, donde de X1 a X4 son cada uno...
COMPOSICIONES PARA SUMINISTRO ORAL
09/04/2025 -
Se relaciona con una forma de dosificacion adecuada para la administracion oral que comprende un peptido o proteina terapeutico en una capsula sellada que tiene un recubrimiento copolimerico. Se...
PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION
19/06/2025 -
A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container...
ELECTROMAGNETIC DROP-ON-DEMAND (DOD) TECHNOLOGY AS AN INNOVATIVE PLATFORM FOR AMORPHOUS SOLID DISPERSION PRODUCTION
19/06/2025 -
Described are continuous manufacturing methods using 3D printing or any similar additive manufacturing technology to produce pharmaceutical ASDs. Manufacturing methods include preparing printing...
ELECTROMAGNETIC DROP-ON-DEMAND (DOD) TECHNOLOGY AS AN INNOVATIVE PLATFORM FOR AMORPHOUS SOLID DISPERSION PRODUCTION
19/06/2025 -
Described are continuous manufacturing methods using 3D printing or any similar additive manufacturing technology to produce pharmaceutical ASDs. Manufacturing methods include preparing printing...
Recipiente moldeado apilable fabricado en material termoplástico y provisto de un asa.
30/05/2025 -
La invención se refiere a un recipiente moldeado (100), en particular un recipiente moldeado por soplado, para alojar un preparado, en particular un preparado médico y/o farmacéutico (2), y...
COMPUESTOS DE FÁRMACOS CON UNA PORCIÓN DE UNIÓN DE ALBÚMINA
21/05/2025 -
Compuestos o sales aceptables desde el punto de vista farmacéutico de estos, en donde los compuestos comprenden al menos una porción polimérica, al que al menos dos porciones de fármaco están...
CONTROLLED-RELEASE FORMULATION FOR ORAL ADMINISTRATION COMPRISING MELATONIN, AND PREPARATION METHOD THEREFOR
05/06/2025 -
The present invention relates to an orally administered formulation comprising melatonin as an active ingredient and having a drug-release controlling property, and a method for preparing same by...
RECYCLABLE BLISTER PACKAGE
04/06/2025 -
A blister package is provided that includes a base made from cyclic olefin copolymer (COC) and a lidding film that includes polyolefin layer(s) or a combination of polyolefin and COC layers, that...
PHARMACEUTICAL COMPOSITION COMPRISING NOVEL TEREPHTHALATE-CYCLOHEXYLAMINE-BASED POLYMER COMPOUND FOR PHOTODYNAMIC THERAPY FOR GLIOBLASTOMA
30/05/2025 -
The present invention relates to a pharmaceutical composition comprising a novel terephthalate-cyclohexylamine-based polymer compound for photodynamic therapy for glioblastoma, wherein the polymer...
RECYCLABLE BLISTER PACKAGE
04/06/2025 -
A blister package is provided that includes a base made from cyclic olefin copolymer (COC) and a lidding film that includes polyolefin layer(s) or a combination of polyolefin and COC layers, that...
PHARMACEUTICAL COMPOSITION COMPRISING NOVEL TEREPHTHALATE-CYCLOHEXYLAMINE-BASED POLYMER COMPOUND FOR PHOTODYNAMIC THERAPY FOR GLIOBLASTOMA
30/05/2025 -
The present invention relates to a pharmaceutical composition comprising a novel terephthalate-cyclohexylamine-based polymer compound for photodynamic therapy for glioblastoma, wherein the polymer...
NOVEL HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS DNA POLYMERASE THETA INHIBITORS FOR THE PREVENTION OR TREATMENT OF CANCER
30/05/2025 -
The present disclosure relates to a novel heterocyclic compound represented by the Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the...
